Trial intelligence / Profile preview

Dressings for pain and infection at skin graft donor sites

IRCT20190325043107N5Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Jul 2019
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial in burn injury comparing Vaseline gauze dressing, Mupirocin 2% dressing and Nitrofurazone dressing (3 arms). Primary endpoints: Pain and Infection. Started Jul 2019; status: completed.

02

Drugs

mupirocinnitrofurazonepetrolatum
03

Conditions

burn injury

Beyond the preview

Go deeper on IRCT20190325043107N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190325043107N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call